AzTrials
AzTrials

Hemiplegic Shoulder PainNCT04292613

"The Effect of Hemiplegic Shoulder Pain on Balance, Upper Extremity Function and Quality of Life"

An observational study of Hemiplegic Shoulder Pain, run by Istanbul University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

"The Effect of Hemiplegic Shoulder Pain on Balance, Upper Extremity Function and Quality of Life" Read more about this study

Who is it for?
Ages 40 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Hemiplegic Shoulder Pain
What is being tested?
"The Effect of Hemiplegic Shoulder Pain on Balance, Upper Extremity Function and Quality of Life"
How many people
48 participants
Where
1 siteTurkey (Türkiye)
Study dates
5 Mar 2020to 3 Aug 2020
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: hemiplegic shoulder pain

Who may be able to join

  • Having had a cerebrovascular accident
  • Ages ranging from 40 to 75
  • Right or left hemiplegic
  • Without mental problems
  • Cooperative
  • According to Brunnstrom staging, upper extremity stage 1-2-3-4-5

Who cannot join

  • who do not want to be evaluated
  • Under the age of 40 and over the age of 75
  • Non-cooperative
  • Another orthopedic shoulder problem
  • Newly operated patients will not be included in the study.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Physical Therapy and Rehabilitation Training and Research Hospital

    Bahçelievler, Istanbul, 34180

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Hemiplegic Shoulder Pain on Balance, Upper Extremity Function and Quality of Life"

"The Effect of Hemiplegic Shoulder Pain on Balance, Upper Extremity Function and Quality of Life"

Read the detailed description

Hemiplegic shoulder pain is a common symptom. Our aim in this study is to investigate the relationship between hemiplegic shoulder pain and balance and upper extremity functions.

Being tested
"The Effect of Hemiplegic Shoulder Pain on Balance, Upper Extremity Function and Quality of Life"
Keywords
shoulder pain, hemiplegic, function, balance
Medical subject headings
Shoulder Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • "The Effect of Hemiplegic Shoulder Pain on Balance, Upper Extremity Function and Quality of Life"Other

    The Effect of Hemiplegic Shoulder Pain on Balance, Upper Extremity Function and Quality of Life"

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Upper Extremite Fugl-Meyer Assessment (UA-FMA)

    Upper Extremite Fugl-Meyer Assessment (UA-FMA) is a scale that evaluates upper extremity functionality. The total score is at least 0 and at most 66 and the high scores are positively correlated with the normal function.

    Measured: 1 day (Evaluation will be done once)

Secondary outcomes (3)
  1. McGill Melzack Pain Questionnaire

    McGill Melzack Pain Questionnaire is used to assess pain. High scores are positively correlated with pain.

    Measured: 1 day (Evaluation will be done once)

  2. Short Form- 36

    SF-36 will be used to assess physical and mental health-related quality of life. The total score is at least 0 and at most 100, and the high scores are positively correlated with high quality of life.

    Measured: 1 day (Evaluation will be done once)

  3. Berg Balance Scale

    Berg balance scale is a scale used to evaluate balance.The total score is at least 0 and at most 56, and the high scores are negatively correlated with high quality of life.

    Measured: 1 day (Evaluation will be done once)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2020
  2. Study start5 Mar 2020
  3. Primary completion22 Jul 2020
  4. Study completion3 Aug 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
48 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT04292613
Sponsor's protocol ID
''SBU''
Status last verified
Aug 2020
First submitted
1 Mar 2020
Last updated
4 Aug 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hemiplegic Shoulder Pain, run by Istanbul University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Upper Extremite Fugl-Meyer Assessment (UA-FMA) (time frame: 1 day (Evaluation will be done once)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in